This site is intended for healthcare professionals only
LoginRegister
AstraZeneca Pharma India gets CDSCO nod for expanded use of Imfinzi in Endometrial CancerAstraZeneca Tagrisso approved in EU for patients with unresectable EGFR-mutated lung cancer
JnJ seeks indication extension of Akeega from EMA for adults with metastatic hormone-sensitive prostate cancer, HRR gene alterationsJnJ enters licensing agreement for global development, manufacturing, commercialization of STAT6...
PfizerPfizer Gets CDSCO Panel nod to Import Abrocitinib tablets for moderate to severe atopic dermatitis
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaMerck to discontinue bacterial infection drug Zinplava
Amit Agrawal takes charge as Secretary of Department of PharmaAmit Agrawal takes charge as Secretary of Department of Pharma
Illegal Alprazolam Unit Busted in Andhra, 8 Arrested, Drugs Worth Rs 24 Crore SeizedProhibited drugs worth over Rs 25 lakh seized; medical store owner, 2 others arrested
Gland Pharma bags USFDA nod for Cangrelor for InjectionGland Pharma arm Fontenay facility gets 10 observations from France drug regulator
WHO calls for transformative action towards greener future in pharmaceutical manufacturing, distributionWHO calls for transformative action towards greener future in pharmaceutical manufacturing,...
BDR Pharmaceuticals Gets CDSCO Panel Nod for bioequvalence study of Abiraterone Acetate Oral SuspensionBDR Pharmaceuticals Gets CDSCO Panel Nod for bioequvalence study of Abiraterone Acetate Oral...
Parliamentary Panel Slams NPPA for 50% Price Hike, Demands AnswersParliamentary Panel Slams NPPA for 50% Price Hike, Demands Answers
USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers SquibbBristol Myers Squibb gets European Commission nod for Opdivo plus Yervoy to treat colorectal cancer
GPT Healthcare shares listed with over 16 percent premiumGPT Healthcare shares listed with over 16 percent premium
X